Company Filing History:
8 out of 4,455 
1 out of 47 
1 out of 832,843 Years Active: 2002-2010
Title: **Kevin K Liu: Innovator in Pharmaceutical Technologies**
Introduction
Kevin K Liu is a notable inventor located in East Lyme, CT, USA. With an impressive portfolio of 9 patents, he has made significant contributions to the fields of pharmaceuticals and therapeutic treatments. His work focuses on innovative compounds that address various health issues related to bone and mineral homeostasis, as well as glucocorticoid receptor modulation.
Latest Patents
Among Kevin's recent inventions are novel pyrido[4,3-d]pyrimidin-4(3H)-one derivatives, which include pharmaceutically acceptable salts. These compounds are designed to treat conditions such as hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fractures, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy. Additionally, he has developed non-steroidal glucocorticoid receptor modulators that serve as selective agonists and antagonists of the glucocorticoid receptor. These modulators are beneficial for treating diseases such as obesity, diabetes, and inflammation, along with providing intermediates and processes for their preparation.
Career Highlights
Kevin has worked with leading pharmaceutical companies, most notably Pfizer Corporation and Pfizer Products Inc. His valuable experience and expertise in research and development have allowed him to excel in his field, promoting innovations that enhance therapeutic options for patients.
Collaborations
Throughout his career, Kevin has collaborated with talented individuals such as Bradley Paul Morgan and Robert L Dow. These partnerships have fostered an environment for innovation, leading to the development of groundbreaking pharmaceuticals.
Conclusion
Kevin K Liu is a prominent figure in the realm of pharmaceutical inventions, with a focus on novel treatments for various medical conditions. His ongoing contributions, through the development of innovative compounds and collaborations with esteemed colleagues, continue to shape the future of medicine and patient care.